![](/img/cover-not-exists.png)
P399 Cost-effectiveness of utilising proactive Infliximab therapeutic drug monitoring for inflammatory bowel disease in routine clinical practice
Steen, J, McCormack, M, McShane, C, Healy, M, Crowley, V, Kennedy, U, Hayes, O, Dunne, C, Hartery, K, McKiernan, S, MacCarthy, F, Kevans, DVolume:
13
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.523
Date:
January, 2019
File:
PDF, 491 KB
english, 2019